Drug Trial Radar · NCT05523765
A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
Last checked: Nov 19, 2026Latest source record: Jul 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
26
Actual
Start
Nov 14, 2022
Primary completion
Jul 30, 2024
Study completion Jul 30, 2024
Sponsor
- Lead sponsor
- Priovant Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with active intermediate, posterior, or pan non-infectious uveitis (NIU).
Conditions
- Non-infectious Intermediate Uveitis
- Non-infectious Posterior Uveitis
- Non-infectious Pan Uveitis
Interventions
BrepocitinibDrug
Oral Brepocitinib
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: Screening up to 28 days after the last dose of study drug at 52 weeks
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Palo Alto, California
Clinical Trial Site
Pasadena, California
Clinical Trial Site
Lakewood, Colorado
Clinical Trial Site
Waltham, Massachusetts
Clinical Trial Site
St Louis, Missouri
Clinical Trial Site
Palisades Park, New Jersey
Clinical Trial Site
Durham, North Carolina
Clinical Trial Site
Winston-Salem, North Carolina
Clinical Trial Site
Eugene, Oregon
Clinical Trial Site
Nashville, Tennessee
Clinical Trial Site
Bellaire, Texas
Clinical Trial Site
Katy, Texas
Clinical Trial Site
Plano, Texas
Clinical Trial Site
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.